All Stories

  1. Physiological aspects of nitro drug resistance in Giardia lamblia

    Article • International Journal for Parasitology Drugs and Drug Resistance, August 2018, Elsevier

    Dr Joachim Müller

  2. Modulation of cis- and trans- Golgi and the Rab9A-GTPase during infection by Besnoitia besnoiti , Toxoplasma gondii and Neospora caninum

    Article • Experimental Parasitology, February 2018, Elsevier

    Dr Joachim Müller

  3. Activities of 11-Azaartemisinin and N -Sulfonyl Derivatives against Neospora caninum and Comparative Cytotoxicities

    Article • ChemMedChem, December 2017, Wiley

    Dr Joachim Müller

  4. In vitro screening of the open source Pathogen Box identifies novel compounds with profound activities against Neospora caninum

    Article • International Journal for Parasitology, October 2017, Elsevier

    Dr Joachim Müller

  5. Vaccines and drugs against Neospora caninum, an important apicomplexan causing abortion in cattle and other farm animals [Corrigendum]

    Article • Reports in Parasitology, May 2016, Dove Medical Press

    Professor Andrew Hemphill, Dr Joachim Müller

  6. In VitroScreening of the Open-Source Medicines for Malaria Venture Malaria Box Reveals Novel Compounds with Profound Activities against Theileria annulata Schizonts

    Article • Antimicrobial Agents and Chemotherapy, March 2016, ASM Journals

    Professor Andrew Hemphill, Dr Joachim Müller

  7. N-terminal fusion of a toll-like receptor 2-ligand to a Neospora caninum chimeric antigen efficiently modifies the properties of the specific immune response

    Article • Parasitology, March 2016, Cambridge University Press

    Dr Joachim Müller

  8. Giardia

    Article • January 2016, Springer Science + Business Media

    Dr Joachim Müller

  9. Approaches for the vaccination and treatment of Neospora caninum infections in mice and ruminant models

    Article • Parasitology, December 2015, Cambridge University Press

    Professor Andrew Hemphill, Dr Joachim Müller

  10. Vaccines and drugs against Neospora caninum, an important apicomplexan causing abortion in cattle and other farm animals

    Article • Reports in Parasitology, September 2015, Dove Medical Press

    Professor Andrew Hemphill, Dr Joachim Müller

  11. In vitro effects of new artemisinin derivatives in Neospora caninum-infected human fibroblasts

    Article • International Journal of Antimicrobial Agents, July 2015, Elsevier

    Dr Joachim Müller

  12. Dose-dependent effects of experimental infection with the virulent Neospora caninum Nc-Spain7 isolate in a pregnant mouse model

    Article • Veterinary Parasitology, July 2015, Elsevier

    Dr Joachim Müller

  13. Profound Activity of the Anti-cancer Drug Bortezomib against Echinococcus multilocularis Metacestodes Identifies the Proteasome as a Novel Drug Target for Cestodes

    Article • PLoS Neglected Tropical Diseases, December 2014, PLOS

    Dr Joachim Müller

  14. Treatment of echinococcosis: albendazole and mebendazole – what else?

    Article • Parasite, January 2014, EDP Sciences

    Dr Joachim Müller

  15. Metabolism of nitro drugs metronidazole and nitazoxanide in Giardia lamblia: characterization of a novel nitroreductase (GlNR2)

    Article • Journal of Antimicrobial Chemotherapy, April 2013, Oxford University Press (OUP)

    Dr Joachim Müller

  16. New Approaches for the Identification of Drug Targets in Protozoan Parasites

    Article • January 2013, Elsevier

    Professor Andrew Hemphill, Dr Joachim Müller

  17. Thiazolides, a Novel Class of Anti-Infective Drugs, Effective Against Viruses, Bacteria, Intracellular and Extracellular Protozoan Parasites and Proliferating Mammalian Cells

    Article • Anti-Infective Agents, November 2012, Bentham Science Publishers

    Professor Andrew Hemphill, Dr Joachim Müller

  18. Drug Target Identification in Intracellular and Extracellular Protozoan Parasites

    Article • Current Topics in Medicinal Chemistry, August 2011, Bentham Science Publishers

    Professor Andrew Hemphill, Dr Joachim Müller

  19. Drugs and Drug Targets inNeospora caninumand Related Apicomplexans

    Article • February 2011, Wiley

    Professor Andrew Hemphill, Dr Joachim Müller

  20. Echinococcus multilocularis phosphoglucose isomerase (EmPGI): A glycolytic enzyme involved in metacestode growth and parasite–host cell interactions

    Article • International Journal for Parasitology, November 2010, Elsevier

    Professor Andrew Hemphill, Dr Joachim Müller

  21. Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites

    Article • International Journal for Parasitology, October 2009, Elsevier

    Professor Andrew Hemphill, Dr Joachim Müller

  22. Identification of differentially expressed genes in a Giardia lamblia WB C6 clone resistant to nitazoxanide and metronidazole

    Article • Journal of Antimicrobial Chemotherapy, April 2008, Oxford University Press (OUP)

    Dr Joachim Müller

  23. Neospora caninum: Functional inhibition of protein disulfide isomerase by the broad-spectrum anti-parasitic drug nitazoxanide and other thiazolides

    Article • Experimental Parasitology, January 2008, Elsevier

    Professor Andrew Hemphill, Dr Joachim Müller

  24. Structure-Function Relationship of Thiazolides, a Novel Class of Anti-Parasitic Drugs, Investigated in Intracellular and Extracellular Protozoan Parasites and Larval-Stage Cestodes

    Article • Anti-Infective Agents in Medicinal Chemistry, October 2007, Bentham Science Publishers

    Professor Andrew Hemphill, Dr Joachim Müller

  25. Induction of tachyzoite egress from cells infected with the protozoan Neospora caninum by nitro- and bromo-thiazolides, a class of broad-spectrum anti-parasitic drugs

    Article • International Journal for Parasitology, August 2007, Elsevier

    Professor Andrew Hemphill, Dr Joachim Müller

  26. Characterization of Giardia lamblia WB C6 clones resistant to nitazoxanide and to metronidazole

    Article • Journal of Antimicrobial Chemotherapy, June 2007, Oxford University Press (OUP)

    Dr Joachim Müller